Liver-protecting oyster oligopeptide solid beverage and preparation method thereof
Through the preparation of liver-protecting oyster oligopeptide solid beverages, combined with enzymatic decomposition and ultra-high pressure concentration technology, the problems of unacceptable taste and major side effects in the existing technology have been solved, and the liver protection effect has been achieved at multiple angles, significantly improving the liver. degree of injury and improve quality of life.
Patent Information
- Application Number
- CN202411187711.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-12-03
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art is difficult to provide a liver protection composition with easy taste for preventing liver damage. It is more irritating and has greater side effects in pure traditional Chinese medicine and has greater health food.
Use liver-protecting oyster oligopeptide solid beverage, which consists of oyster peptide powder, acne date extract, L-cysteine, Pueraria root powder, glutathione yeast extract, needle cherry powder, turmeric, fructose oligosaccharide, cherry powder It consists of powder, resistant dextrin, xylitol and prickly juice powder, and is prepared by enzymatic decomposition, ultra-high pressure concentration and spray drying technology to form a solid beverage that is easy to take.
The composition has multiple angles of liver protection effects, including moistening the intestines, regulating mood, improving immunity, anti-cancer, lowering blood pressure, sobering up and relieving alcohol, promoting liver metabolism and reducing liver damage, significantly improving the degree of liver damage, and significantly improving the degree of liver damage. , improve patients' confidence in treatment and quality of life.
Smart Images

Figure CN119054908A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of marine biological oligopeptides, and in particular to a liver-protecting oyster oligopeptide solid beverage and a preparation method thereof. Background Art
[0002] Nowadays, due to life pressure, environmental pollution and accelerated pace of life, staying up late, drinking and other unhealthy conditions are more common. The above behaviors cause more damage to the liver, and the liver is one of the most important organs in the human body. It plays an important role in deoxidation, storing glycogen, and synthesizing secretory proteins. The liver also produces bile in the digestive system. Most liver diseases will have symptoms of jaundice, which is because the liver cannot continue to excrete bilirubin, so it accumulates in the body. Traditional Chinese medicine believes that the liver and gallbladder are the exterior and interior of each other, opening the eyes. The liver is responsible for storing blood, and the gallbladder is responsible for dredging and has the function of storing and regulating blood. "Suwen Five Internal Organs" says: "The liver is the combination of tendons, and its glory is the nails." The liver is also the general's official, responsible for planning and thinking.
[0003] In order to deal with liver damage, existing Chinese and Western medicine have carried out intervention treatment from different angles. However, pure Chinese medicine is not accepted by some people because of its irritating taste, while pure Western medicine has large side effects and is not convenient for prevention and health care. Therefore, for the sake of physical health, modern people often use diet therapy, that is, eat ingredients with corresponding medicinal effects. Medicine and food have the same origin means that many foods are medicines, and there is no absolute dividing line between them. Ancient medical scientists applied the theory of "four properties" and "five flavors" of traditional Chinese medicine to food, and believed that each food also has "four properties" and "five flavors". The "Notice on Further Standardizing the Management of Health Food Ingredients" issued by the Ministry of Health made specific provisions on medicine and food, items that can be used in health foods, and items prohibited in health foods.
[0004] In recent years, scientists believe that the body absorbs protein mainly in the form of peptides. Peptides are molecules composed of amino acids with a molecular weight between 5000 and 200 Da. They have extremely strong activity and diversity. They can use the physiological functions and biological activities of peptide nutrition to regulate the physiological functions of various systems and cells in the human body and activate related enzymes in the body. Therefore, various peptides have become important substances for human health. Oyster peptides are small molecule oligopeptides obtained from proteins extracted from oyster meat powder through directional enzymatic cleavage and specific small peptide separation technology.
[0005] Oysters, belonging to the phylum Mollusca, class Lanellibranchia, order Anisomyaria, family Ostreidae, are commonly known as sea oysters. They are one of the four major cultured shellfish in my country and are also the first batch of functional foods approved by the Ministry of Health of my country for both medicinal and health care. Oysters have a high protein content and are a good raw material for preparing bioactive peptides. The content of active peptides naturally present in marine organisms is low, and it is difficult to extract and mass produce; chemical synthesis of peptides is time-consuming, labor-intensive, and expensive, so more and more people use enzymatic methods to extract active peptides from marine biological proteins. Fresh oyster meat is bluish-white, soft and tender, with a prominent umami flavor, a fishy smell, and a unique taste. It is a high-protein, low-fat food rich in glycogen, taurine, and a large number of active elements. It is also a medicinal material in traditional medicine. With the deepening of modern medical research, it has been found that oysters also have a variety of biological activities, such as improving the body's immunity, anti-tumor, and protective effects on the liver, which has attracted the attention of researchers. At present, oysters have been proven to have the effects of protecting the liver and lowering lipids. Studies have found that oyster water-soluble polysaccharide extracts can reduce the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and malondialdehyde (MDA) in the serum of mice with acute liver injury. However, due to the unique taste of oysters, it is difficult for the public to accept them if they are not processed cleanly.
[0006] Therefore, how to provide a liver protection composition that is easy to accept in taste and can play a preventive role is an urgent problem to be solved by those skilled in the art. Summary of the invention
[0007] The purpose of the present invention is to solve at least one of the technical problems existing in the prior art and to provide a liver-protecting oyster oligopeptide solid beverage and a preparation method thereof.
[0008] To achieve the above-mentioned purpose, the technical scheme adopted by the present invention is as follows: a liver-protecting oyster oligopeptide solid beverage, composed of the following raw materials in weight percentage: 20-30% oyster peptide powder, 3-7% jujube extract, 3-7% L-cysteine, 1-5% kudzu root powder, 5-10% glutathione yeast extract, 13-15% acerola cherry powder, 1-5% turmeric, 1-3% oligofructose, 6-10% inulin, 3-7% resistant dextrin, 8-12% xylitol, and 13-15% roxburghii juice powder.
[0009] Furthermore, it is composed of the following raw materials in percentage by weight: 25% oyster peptide powder, 5% jujube extract, 5% L-cysteine, 2.5% kudzu root powder, 7% glutathione yeast extract, 14% acerola powder, 3.5% turmeric, 2% oligofructose, 7% inulin, 5% resistant dextrin, 10% xylitol, and 14% sea buckthorn juice powder.
[0010] A method for preparing a liver-protecting oyster oligopeptide solid beverage, wherein the method for preparing the liver-protecting oyster oligopeptide solid beverage is as follows:
[0011] S1. preparing oyster peptide powder;
[0012] S2. Weighing and mixing: Accurately weigh the raw materials according to the formula dosage, put the weighed raw materials into the three-dimensional mixer, seal it, and mix it for 20-40 minutes until it is uniform;
[0013] S3, boiling granulation: turn on the boiling granulation equipment, suck the mixed material into the closed container of the hopper, granulate, dry, and obtain granules with a moisture content of <5%;
[0014] S4, granulation: the granulated particles are sieved through an 80-mesh sieve to obtain relatively uniform particles;
[0015] S5, packaging: put the semi-finished granules into the granule packaging machine, code them and package them;
[0016] S6. Packaging: Put the packaged solid beverages into coded packaging boxes, and seal them with cigarettes after packaging.
[0017] Furthermore, the preparation of oyster peptide powder includes:
[0018] S101, pre-treatment: the frozen oyster plate is first passed through the frozen plate meat grinder and then connected to the colloid mill. After being minced, it is pumped to the feed port of the colloid mill through a vacuum pump and water is added in a 1:1 ratio. At the same time, the flow rate is controlled. After passing through the colloid mill, it is pumped into the enzymatic hydrolysis tank. The steam valve in the interlayer of the enzymatic hydrolysis tank is opened to increase the temperature, stirring is started, and the temperature is set to 56±2℃;
[0019] S102, enzymolysis: after the temperature is constant, add animal protease, papain and neutral protease activated by warm water in advance, stir and enzymolyze for 4-6 hours, and measure the solid content every half an hour with a solids analyzer after 4 hours of enzymolysis. When the solid content is basically stable, the enzymolysis is completed;
[0020] S103, enzyme inactivation: fully open the steam valve, heat up the half-product after enzymatic hydrolysis to inactivate the enzyme, close the steam valve of the enzymatic hydrolysis tank, and pour in ice water to cool it down;
[0021] S103, separation: the cooled semi-product is separated by a tubular centrifuge, and the filtrate is filtered through a plate and frame filter again and then transferred to a temporary storage tank;
[0022] S105, membrane filtration: the semi-product in the temporary storage tank is filtered through a membrane filtration device, passes through a 10,000 Dalton membrane, and the filtrate is collected in a temporary storage tank;
[0023] S106, concentration: the filtrate in the temporary storage tank is sent to a double-effect vacuum concentration device for concentration. After the filtrate is concentrated to a solid content of 15%-20%, it is injected into a blending tank through a pipeline for standby use;
[0024] S107, spray drying: the concentrated enzymatic hydrolysate passes through a homogenizer and then enters a spray tower for spray drying. A dehumidifier is placed on the top of the tower to cool the powder. A vibrating screen is set at the powder outlet, and the powder is screened once every 8-12 minutes to collect the oyster oligopeptide powder.
[0025] Furthermore, it also includes ultra-high pressure concentration: the concentrated liquid is packaged and immersed in an ultra-high pressure treatment pressure transmission medium, wherein the ultra-high pressure treatment parameters are pressure 550-650MPa, temperature 28-32°C, and time 25-35min.
[0026] Furthermore, during the enzymatic hydrolysis, the pH value of the solution is adjusted to pH=6.8 by adding sodium hydroxide.
[0027] Furthermore, the sterilization temperature for inactivating the enzyme is 95-100°C, the holding time is 20-22 minutes, and the temperature is lowered to below 40°C.
[0028] Furthermore, the spray tower inlet temperature of the spray drying is 170-190°C, and the outlet temperature is 95-105°C.
[0029] Furthermore, it also includes unpacking: before each raw material enters the weighing room, the outer packaging bag is removed and replaced with a workshop-specific sterile bag and marked.
[0030] Beneficial effects of the present invention: From the above description of the present invention, it can be seen that compared with the prior art, the composition of the present invention is reasonably matched, nutritionally sufficient, and has some characteristics of medicine and food being of the same origin. It can protect the liver from multiple angles, including vitamins, trace elements, laxative effects, mood regulation, improvement of body immunity, anti-cancer, blood pressure reduction, sobering up, promoting liver metabolism, reducing liver damage and decomposing toxin burden, delaying aging, etc., and can significantly improve the degree of liver damage, and has an auxiliary effect on improving patients' confidence in treatment and improving their quality of life. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 The present invention is a flow chart of a method for preparing a liver-protecting oyster oligopeptide solid beverage in a preferred embodiment of the present invention. DETAILED DESCRIPTION
[0032] The technical solutions in the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments.
[0033] In the description of the present invention, it should be noted that, unless otherwise clearly specified and limited, the terms "connected" and "connection" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0034] The preferred embodiment of the present invention is a liver-protecting oyster oligopeptide solid beverage, which is composed of the following raw materials in weight percentage: 20-30% oyster peptide powder, 3-7% jujube extract, 3-7% L-cysteine, 1-5% kudzu root powder, 5-10% glutathione yeast extract, 13-15% acerola powder, 1-5% turmeric, 1-3% oligofructose, 6-10% inulin, 3-7% resistant dextrin, 8-12% xylitol, and 13-15% roxburghii juice powder. Preferably, it is composed of the following raw materials in weight percentage: 25% oyster peptide powder, 5% jujube extract, 5% L-cysteine, 2.5% kudzu root powder, 7% glutathione yeast extract, 14% acerola powder, 3.5% turmeric, 2% oligofructose, 7% inulin, 5% resistant dextrin, 10% xylitol, and 14% roxburghii juice powder.
[0035] Reference Figure 1 As shown, a method for preparing a liver-protecting oyster oligopeptide solid beverage, the method for preparing the above-mentioned liver-protecting oyster oligopeptide solid beverage is as follows:
[0036] S1. preparing oyster peptide powder;
[0037] S101, pre-treatment: the frozen oyster plate is first passed through the frozen plate meat grinder and then connected to the colloid mill. After being minced, it is pumped to the feed port of the colloid mill through a vacuum pump and water is added in a 1:1 ratio. At the same time, the flow rate is controlled. After passing through the colloid mill, it is pumped into the enzymatic hydrolysis tank. The steam valve in the interlayer of the enzymatic hydrolysis tank is opened to increase the temperature, stirring is started, and the temperature is set to 56±2℃;
[0038] S102, enzymolysis: after the temperature is constant, add animal protease, papain and neutral protease activated by warm water in advance, stir and enzymolyze for 4-6 hours, and measure the solid content every half an hour with a solids analyzer after 4 hours of enzymolysis. When the solid content is basically stable, the enzymolysis is completed;
[0039] S103, enzyme inactivation: fully open the steam valve, heat the semi-product after enzymatic hydrolysis to 98°C, maintain for 20 minutes, inactivate the enzyme, close the steam valve of the enzymatic hydrolysis tank, and pour in ice water to cool it down to below 40°C;
[0040] S104, separation: After the enzymatic hydrolysis is completed and allowed to stand for 5-10 minutes, a 60-mesh filter is connected to the bottom of the enzymatic hydrolysis tank to intercept large residues, and the enzymatic hydrolyzate is filtered through a pipeline filter to a tubular centrifuge for separation. The filtrate is filtered again (so that the generated foam is buffered on the filter) and then connected to a temporary storage bucket;
[0041] S105, membrane filtration: the semi-product in the temporary storage tank is filtered through a membrane filtration device, passes through a 10,000 Dalton membrane, and the filtrate is collected in a temporary storage tank;
[0042] S106, concentration: the filtrate in the temporary storage tank is sent to a double-effect vacuum concentration device for concentration. After the filtrate is concentrated to a solid content of 15%-20%, it is injected into a blending tank through a pipeline for standby use;
[0043] S107, ultra-high pressure concentration: the concentrated liquid is divided and immersed in an ultra-high pressure treatment pressure transmission medium, and the ultra-high pressure treatment parameters are set to perform ultra-high pressure treatment at 600 MPa, 30° C., and 30 min;
[0044] S108, spray drying: the concentrated enzymatic hydrolysate is passed through a homogenizer and then into a spray tower for spray drying. The inlet temperature of the spray tower is 180°C and the outlet temperature is 100°C. A dehumidifier is placed on the top of the tower to cool the powder. A vibrating screen is set at the powder outlet, and the powder is screened once every 8-12 minutes to collect the oyster oligopeptide peptide powder.
[0045] S2. Weighing and mixing: Accurately weigh the raw materials according to the formula dosage, put the weighed raw materials into the three-dimensional mixer, seal it, and mix it for 20-40 minutes until it is uniform;
[0046] Before each raw material enters the weighing room, remove the outer packaging bag, replace it with a workshop-specific sterile bag and mark it;
[0047] S3, boiling granulation: turn on the boiling granulation equipment, suck the mixed material into the closed container of the hopper, granulate, dry, and obtain granules with a moisture content of <5%;
[0048] S4, granulation: the granulated particles are sieved through an 80-mesh sieve to obtain relatively uniform particles;
[0049] S5, packaging: put the semi-finished granules into the granule packaging machine, code them and package them;
[0050] S6. Packaging: Put the packaged solid beverages into coded packaging boxes, and seal them with cigarettes after packaging.
[0051] The liver-protecting oyster oligopeptide solid beverage prepared above was applied to animals with chronic liver damage, and the experimental process and results are described as follows.
[0052] 1. Method for establishing chronic liver injury model
[0053] ICR male mice were gavaged with oyster oligopeptide solid beverage once a day, and intraperitoneally injected with 2.5% carbon tetrachloride (CCL4) oil solution once every 3 days. The experimental period was 30 days. After the last injection, the mice were fasted but not watered for 24 hours before being sampled. The relevant gavage doses are shown in Table 1
[0054] 2. Experimental Grouping
[0055] Table 1 Oral gavage dose and grouping
[0056]
[0057] 3. Experimental results
[0058] 3.1 Effects of ultra-high pressure oyster oligopeptide solid beverage on liver injury in mice with chronic liver injury induced by CCL4
[0059] Table 1 Effects of ultra-high pressure oyster oligopeptide solid beverage on serum ALT and AST in mice with chronic liver injury
[0060]
[0061]
[0062] Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are important indicators for measuring liver damage. As shown in Table 1, oyster oligopeptide solid beverage can significantly improve liver damage, and has a significant dose-dependent effect. The solid beverage-600 reduced serum ALT and AST by 44.30% and 52.31%, respectively, which is equivalent to the positive drug.
[0063] 3.2 Effects of ultra-high pressure oyster oligopeptide solid beverage on lipid synthesis and metabolism in mice with chronic liver injury induced by CCL4
[0064] Table 2 Effects of ultra-high pressure oyster oligopeptide solid beverage on serum TC and TG in mice with chronic liver injury
[0065]
[0066] The liver is an important organ for the synthesis of cholesterol and triglycerides. Serum total cholesterol (TC) and triglycerides (TG) are one of the indicators for judging the condition of patients with liver disease. As shown in Table 4, solid beverage-600 increased serum TC by 17.27% and TG by 26.62%, which is better than positive drugs.
[0067] 3.3 Effects of ultra-high pressure oyster oligopeptide solid beverage on peroxidation in mice with chronic liver injury induced by CCL4
[0068] Table 3 Effects of ultra-high pressure oyster oligopeptide solid beverage on serum / liver SOD and MDA in mice with chronic liver injury
[0069]
[0070] Superoxide dismutase (SOD) and malondialdehyde (MDA) are important markers of oxidative stress. When an organism is subjected to external oxidative stimulation, the SOD value in serum increases, the SOD in the liver decreases significantly, and the MDA increases. As shown in Table 2, the ultra-high pressure oyster oligopeptide solid beverage can significantly improve oxidative stress, and has a significant dose-dependent effect. The solid beverage-600 reduced serum SOD by 9.61% and serum MDA by 39.28%; liver SOD increased by 31.25%, and liver MDA decreased by 41.31%, which is equivalent to the positive drug.
[0071] 3.4 Effects of ultra-high pressure oyster oligopeptide solid beverage on inflammation and fibrosis in mice with chronic liver injury induced by CCL4
[0072] Table 4 Effects of ultra-high pressure oyster oligopeptide solid beverage on serum / liver TNF-α and TGF-β1 in mice with chronic liver injury
[0073]
[0074] Tumor necrosis factor (TNF-α) is an important marker of inflammation, and transforming growth factor (TGF-β1) is an important marker of liver fibrosis. As shown in Table 3, ultra-high pressure oyster oligopeptide solid beverage can significantly improve inflammation and fibrosis, and has a significant dose-dependent effect. Solid beverage-600 reduces serum TNF-α by 17.54%, serum TGF-β1 by 10.55%, and liver TNF-α by 41.08%, which is equivalent to positive drugs.
[0075] Under the premise that no conflict occurs, those skilled in the art may freely combine and superimpose the above-mentioned additional technical features.
[0076] It is to be understood that the present invention is described by some embodiments, and it is known to those skilled in the art that various changes or equivalent substitutions may be made to these features and embodiments without departing from the spirit and scope of the present invention. In addition, under the teachings of the present invention, these features and embodiments may be modified to adapt to specific circumstances and materials without departing from the spirit and scope of the present invention. Therefore, the present invention is not limited by the specific embodiments disclosed herein, and all embodiments falling within the scope of the claims of this application are within the scope of protection of the present invention.
Claims
1. A liver-protecting oyster oligopeptide solid beverage, characterized in that: The invention is composed of the following raw materials in percentage by weight: 20-30% of oyster peptide powder, 3-7% of jujube extract, 3-7% of L-cysteine, 1-5% of kudzu root powder, 5-10% of glutathione yeast extract, 13-15% of acerola powder, 1-5% of turmeric, 1-3% of oligofructose, 6-10% of inulin, 3-7% of resistant dextrin, 8-12% of xylitol and 13-15% of roxburghii juice powder.
2. The liver-protecting oyster oligopeptide solid beverage according to claim 1 is characterized by: The invention is composed of the following raw materials in percentage by weight: 25% oyster peptide powder, 5% jujube extract, 5% L-cysteine, 2.5% kudzu root powder, 7% glutathione yeast extract, 14% acerola powder, 3.5% turmeric, 2% oligofructose, 7% inulin, 5% resistant dextrin, 10% xylitol and 14% roxburghii juice powder.
3. A method for preparing a liver-protecting oyster oligopeptide solid beverage, characterized in that: The method for preparing the liver-protecting oyster oligopeptide solid beverage according to any one of claims 1 to 2 is as follows: S1. preparing oyster peptide powder; S2. Weighing and mixing: Accurately weigh the raw materials according to the formula dosage, put the weighed raw materials into the three-dimensional mixer, seal it, and mix it for 20-40 minutes until it is uniform; S3, boiling granulation: turn on the boiling granulation equipment, suck the mixed material into the closed container of the hopper, granulate, dry, and obtain granules with a moisture content of <5%; S4, granulation: the granulated particles are sieved through an 80-mesh sieve to obtain relatively uniform particles; S5, packaging: put the semi-finished granules into the granule packaging machine, code them and package them; S6. Packaging: Put the packaged solid beverages into coded packaging boxes, and seal them with cigarettes after packaging.
4. The method for preparing the liver-protecting oyster oligopeptide solid beverage according to claim 3, characterized in that: The preparation of the oyster peptide powder comprises: S101, pre-treatment: the frozen oyster plate is first passed through the frozen plate meat grinder and then connected to the colloid mill. After being minced, it is pumped to the feed port of the colloid mill through a vacuum pump and water is added in a 1:1 ratio. At the same time, the flow rate is controlled. After passing through the colloid mill, it is pumped into the enzymatic hydrolysis tank. The steam valve in the interlayer of the enzymatic hydrolysis tank is opened to increase the temperature, stirring is started, and the temperature is set to 56±2℃; S102, enzymolysis: after the temperature is constant, add animal protease, papain and neutral protease activated by warm water in advance, stir and enzymolyze for 4-6 hours, and measure the solid content every half an hour with a solids analyzer after 4 hours of enzymolysis. When the solid content is basically stable, the enzymolysis is completed; S103, enzyme inactivation: fully open the steam valve, heat up the half-product after enzymatic hydrolysis to inactivate the enzyme, close the steam valve of the enzymatic hydrolysis tank, and pour in ice water to cool it down; S103, separation: the cooled semi-product is separated by a tubular centrifuge, and the filtrate is filtered through a plate and frame filter again and then transferred to a temporary storage tank; S105, membrane filtration: the semi-product in the temporary storage tank is filtered through a membrane filtration device, passes through a 10,000 Dalton membrane, and the filtrate is collected in a temporary storage tank; S106, concentration: the filtrate in the temporary storage tank is sent to a double-effect vacuum concentration device for concentration. After the filtrate is concentrated to a solid content of 15%-20%, it is injected into a blending tank through a pipeline for standby use; S107, spray drying: the concentrated enzymatic hydrolysate passes through a homogenizer and then enters a spray tower for spray drying. A dehumidifier is placed on the top of the tower to cool the powder. A vibrating screen is set at the powder outlet, and the powder is screened once every 8-12 minutes to collect the oyster oligopeptide powder.
5. The method for preparing the liver-protecting oyster oligopeptide solid beverage according to claim 4, characterized in that: It also includes ultra-high pressure concentration: the concentrated liquid is packaged and immersed in an ultra-high pressure treatment pressure transmission medium, wherein the parameters of the ultra-high pressure treatment are pressure 550-650MPa, temperature 28-32°C, and time 25-35min.
6. The method for preparing the liver-protecting oyster oligopeptide solid beverage according to claim 4, characterized in that: The pH value of the solution is adjusted to 6.8 by adding sodium hydroxide during the enzymatic hydrolysis.
7. The method for preparing the liver-protecting oyster oligopeptide solid beverage according to claim 4, characterized in that: The enzyme inactivation sterilization temperature is 95-100°C, the holding time is 20-22 minutes, and the temperature is lowered to below 40°C.
8. The method for preparing the liver-protecting oyster oligopeptide solid beverage according to claim 4, characterized in that: The spray tower inlet temperature of the spray drying is 170-190°C, and the outlet temperature is 95-105°C.
9. The method for preparing the liver-protecting oyster oligopeptide solid beverage according to claim 3, characterized in that: It also includes unpacking: before each raw material enters the weighing room, the outer packaging bag is removed and replaced with a workshop-specific sterile bag and marked.
